Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Monte Rosa Therapeutics Inc
GLUECurrent price
5.83 USD
-0.02 USD (-0.34%)
Last closed
5.80 USD
Company
www.monterosatx.com
ISIN
US61225M1027
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
471 833 856 USD
Yield for 12 month
-31.09 %
1Y
3Y
5Y
10Y
15Y
GLUE
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops MRT-2359, an orally bioavailable molecular glue degrader targeting the translation termination factor protein GSPT1 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of systemic and central nervous system autoimmune diseases; and MRT-8102 for the treatment of IL-1"/NLRP3 driven inflammatory diseases. It also develops CDK2 to treat ovarian, uterine, and breast cancers. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts. Address: 321 Harrison Avenue, Boston, MA, United States, 02118
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.43 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+9 216 000 USD
Last Quarter
+4 695 000 USD
Current Year
-6 222 000 USD
Last Year
-8 559 000 USD
Current Quarter
+9 216 000 USD
Last Quarter
+2 635 000 USD
Key Figures GLUE
1 year
3 years
5 years
10 years
EBITDA
-121 073 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-28.43 %
PEG Ratio
–
Return On Equity TTM
-61.23 %
Wall Street Target Price
16.43 USD
Revenue TTM
14 975 000 USD
Book Value
3.35 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.78 USD
Diluted Eps TTM
-1.78 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GLUE
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History GLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation GLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
18.25
Price Sales TTM
31.51
Enterprise Value EBITDA
-0.78
Price Book MRQ
2.30
Financials GLUE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLUE
For 52 weeks
3.21 USD
12.40 USD
50 Day MA
7.72 USD
Shares Short Prior Month
11 152 201
200 Day MA
5.90 USD
Short Ratio
8.20
Shares Short
11 054 976
Short Percent
32.87 %
BeatStart